Adaptaquin
CAS No. 385786-48-1
Adaptaquin( —— )
Catalog No. M27498 CAS No. 385786-48-1
Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 72 | Get Quote |
|
| 25MG | 147 | Get Quote |
|
| 50MG | 237 | Get Quote |
|
| 100MG | 372 | Get Quote |
|
| 200MG | 531 | Get Quote |
|
| 500MG | 849 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdaptaquin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
-
DescriptionAdaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorNEK6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number385786-48-1
-
Formula Weight377.82
-
Molecular FormulaC21H16ClN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (264.68 mM)
-
SMILESOc1cccnc1NC(c(cc1)ccc1Cl)c(ccc1cccnc11)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De Donato M, et al. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6. Sci Rep. 2018;8(1):16047. Published 2018 Oct 30.
molnova catalog
related products
-
M1001
M1001 is a HIF-2α?agonist.
-
HIF-2α-IN-3
HIF-2α-IN-3 is a HIF-2α alteration inhibitor with anti-tumor properties and may be used in the study of cardiovascular disease.
-
HIF-1α-IN-2
HIF-1α-IN-2 is a novel and highly potent HIF-1α inhibitor with anticancer and antitumor activity that inhibits the expression of HIF-1α and VEGF in a dose-dependent manner and inhibits cell migration.
Cart
sales@molnova.com